BioSpace News Archive

IND filing today for STI-2020 (COVI-AMG™) for the treatment of COVID-19 in patients with mild symptoms and a separate safety and pharmacokinetic study in healthy volunteers. These initial trials are expected to be followed by pivotal trials with a goal of potentially receiving an EUA (Emergency Use Authorization). Animal model data (golden Syrian hamsters infected with SARS-CoV-2) demonstrated a highly effective neutralizing profile.

Surface Oncology (Nasdaq: SURF), today announced that preclinical data on SRF388, a first in class IL-27 blocking antibody in clinical trials for patients with cancer, and SRF114, a CCR8-selective antibody, will be presented at the Society for Immunotherapy for Cancer’s (SITC) 35th Anniversary Annual Meeting

Disparities in unilateral knee replacement surgery have been well-documented, with lower utilization and higher complication rates among African American patients.

Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pierre Fabre Medical Care R&D teams.

Neurelis, Inc., announced today that the company’s lead product, VALTOCO® (diazepam nasal spray), is now available through pharmacies nationwide

Stardog, the leading Enterprise Knowledge Graph platform, today announced that it has added Katherine Kalin, a former healthcare industry executive, to its Advisory Board.

The Cystic Fibrosis Registry Global Harmonization Group, including the CF Foundation, published in the Journal of Cystic Fibrosis updated data on the impact of COVID-19 on people with cystic fibrosis.

At this year’s American College of Rheumatology virtual meeting, Hospital for Special Surgery presented exciting research related to rheumatology and orthopedic surgery.

WCG, the leading provider of services and solutions that improve and accelerate the conduct of clinical trials, announced that the U.S. Department of Veterans Affairs’ (VA) Office of Research and Development (ORD) is successfully implementing WCG’s IRBNet electronic submission and review system for more than 100 VA medical centers (VAMCs) that have research programs.

Genialis, a leader in applied data science for the development of precision medicines, will present a poster alongside OncXerna (fka Oncologie) at the upcoming Society for Immunotherapy of Cancer conference (SITC 2020)